Dopaminergic News and Research

RSS

Non-invasive brain scanning technique may trace development of Parkinson's disease

While finding a biomarker for Parkinson's disease that would let physicians screen for or track its progression remains an elusive goal, a team led by a University of Illinois at Chicago neuroscientist has shown that a non-invasive brain scanning technique offers promise.

24 Mar 2009

Drug being used to improve cognition affects dopamine, suggesting potential for abuse

Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA.

17 Mar 2009

Virus-free embryonic-like stem cells made from skin of Parkinson's disease patients

Researchers reporting in the March 6th issue of the journal Cell , a Cell Press publication, have developed a new way to produce human embryonic-like stem cells that are free of the viruses used to insert the key ingredients.

5 Mar 2009

New insights into addiction

A new comprehensive review by researchers at the Montreal Neurological Institute (MNI), McGill University and the University of Cambridge, England provides vital insights into the neurological basis of addiction by investigating Parkinson's disease patients, who in some instances develop various addictions when undergoing medical treatment.

25 Feb 2009

Safinamide significantly improved motor function in patients with advanced Parkinson's disease

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.

5 Feb 2009

GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome

GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

16 Sep 2008

Researchers find link between altered dopamine activity and social anxiety disorder

Using single-photon emission computed tomography (SPECT), researchers in The Netherlands were able to detect biochemical differences in the brains of individuals with generalized social anxiety disorder (also known as social phobia), providing evidence of a long-suspected biological cause for the dysfunction.

12 May 2008

Nurse care for schizophrenia patients

Drug and psychosocial interventions for the symptoms of schizophrenic disorders contribute to a lower incidence and prevalence of schizophrenia. Nurses will be able to offer better care through the use of nursing models and theories in the care of Schizophrenics.

6 May 2008

Blood urate levels associated with the progression of Parkinson's disease

Higher blood levels of the compound urate, a salt derived from uric acid that is associated with gout, may be associated with a slower progression of Parkinson's disease, according to an article posted online today that will appear in the June 2008 print issue of Archives of Neurology.

15 Apr 2008

Identification of dopamine 'mother cells' could lead to future Parkinson's treatments

'Mother cells' which produce the neurons affected by Parkinson's disease have been identified by scientists, according to new research published in the journal Glia.

8 Apr 2008

Zebrafish enables cell regeneration studies to help understand, treat human disease

One aquarium fish's uncanny ability to regenerate essentially any cell type has given scientists a way to mimic cell loss that occurs in diseases such as Parkinson's and diabetes then watch how the fish make more of them.

18 Mar 2008

Listening to music in the early stages after a stroke can improve patients' recovery

Researchers from Finland found that if stroke patients listened to music for a couple of hours a day, their verbal memory and focused attention recovered better and they had a more positive mood than patients who did not listen to anything or who listened to audio books.

20 Feb 2008

Risk factors for Parkinson's disease focus of new research

A new study demonstrates that high levels of MAO-B, an enzyme that regulates nerve activity in the brain, cause Parkinson's-like symptoms in mice genetically engineered to overexpress the protein.

20 Feb 2008

Stem cell research aims to tackle Parkinson's disease

Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinson's disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.

21 Jan 2008

Dopaminergic News and Research

Non-invasive brain scanning technique may trace development of Parkinson's disease

Drug being used to improve cognition affects dopamine, suggesting potential for abuse

Virus-free embryonic-like stem cells made from skin of Parkinson's disease patients

New insights into addiction

Safinamide significantly improved motor function in patients with advanced Parkinson's disease

GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome

Researchers find link between altered dopamine activity and social anxiety disorder

Nurse care for schizophrenia patients

Blood urate levels associated with the progression of Parkinson's disease

Identification of dopamine 'mother cells' could lead to future Parkinson's treatments

Zebrafish enables cell regeneration studies to help understand, treat human disease

Listening to music in the early stages after a stroke can improve patients' recovery

Risk factors for Parkinson's disease focus of new research

Stem cell research aims to tackle Parkinson's disease

Trichloroethylene exposure linked to Parkinsonism

Trichloroethylene chemical - widely used in industry - is a risk factor for parkinsonism

Researchers establish risk factors for Parkinson's disease

The dopamine transporter gene influences alcohol withdrawal seizures

Depletion of antioxidant glutathione linked to Parkinson's in mice

Genetic markers for mental illness

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News